Patent ID: 7026112
Filing Date: 2006-04-11
Classification: C12Q

Abstract:
1. A method for determining the presence of EBV-positive nasopharyngeal carcinoma or gastric carcinoma cells in a sample of an individual suspected of or at risk for carrying an EBV associated disease, comprising: (a) amplifying one or more targets from the BKRF1 reading frame spanning nucleotides 107950-109872 of EBNA-1, (b) amplifying one or more target sequence(s) selected from the BARF1 reading frame spanning nucleotides 165504-166166, (c) detecting the presence or absence of the amplified target sequences of steps (a) and (b), and (d) determining the presence of EBV-positive nasopharyngeal carcinoma or gastric carcinoma cells from the presence of the amplified target sequences of steps (a) and (b).